[On the use of estroprogestinics in the control of lactation].
D002741:Chlorotrianisene / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use*; D004997:Ethinyl Estradiol / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007774:Lactation / Q000187:drug effects*; D007775:Lactation Disorders / Q000188:drug therapy; D008234:Lynestrenol / Q000627:therapeutic use; D008656:Mestranol / Q000627:therapeutic use; D009640:Norethindrone / Q000627:therapeutic use; D009641:Norethynodrel / Q000627:therapeutic use; D011247:Pregnancy; D011372:Progestins / Q000627:therapeutic use*
D004967:Estrogens; D011372:Progestins; D004997:Ethinyl Estradiol; D002741:Chlorotrianisene; D009641:Norethynodrel; D008656:Mestranol; D008234:Lynestrenol; D009640:Norethindrone
L'impiego degli estro-progestinici nel controllo della lattazione.